Page 4 - Les Meilleurs doctors - TOP-171 des médecins

Le Dr Herishanu Yair est un hématologue de premier plan, ayant reçu plus de 10 prix pour ses recherches révolutionnaires sur la leucémie lymphoïde chronique (LLC) au centre médical Sourasky.

• Spécialisé dans la LLC – la leucémie la plus courante chez l'adulte
• Lauréat du prestigieux prix d'oncologie Klitzberg
• Membre des associations d'hématologie israélienne et américaine
• Formation approfondie dans les meilleures institutions médicales israéliennes
• Chercheur publié bénéficiant de subventions de l'Israel Science Foundation

Le professeur Drach a réalisé plus de 1 100 interventions oncologiques et a dirigé le programme sur le myélome multiple et le lymphome malin à l'hôpital universitaire de Vienne, l'un des plus grands d'Europe.

• Spécialiste en oncologie hématologique avec plus de 25 ans d'expérience
• Ancien médecin-chef de la clinique universitaire de médecine interne I de Vienne
• A publié plus de 120 articles scientifiques sur l'hématologie et l'oncologie
• Membre du conseil d'administration de la Société autrichienne d'hématologie et d'oncologie
• Propose des seconds avis et l'optimisation des thérapies pré-chirurgicales

Le Dr Carmen Martínez Chamorro se spécialise dans les greffes de moelle osseuse chez l'adulte pour les leucémies, les lymphomes et les myélomes au sein de Quironsalud Madrid.

• Chef adjointe du service d'hématologie à Quironsalud Madrid
• Auteur de 20 articles médicaux et participante à 60 conférences
• Formée à l'hôpital universitaire La Princesa de Madrid
• Lauréate du prix national de recherche en chirurgie

Le professeur Hasan Atilla Ozkan dirige l'Association turque d'aphérèse thérapeutique et se spécialise dans la transplantation de cellules souches à l'hôpital VM Medical Park Pendik.

• Plus de 20 ans d'expérience en hématologie et en transplantation de moelle osseuse
• Certifié en transplantation de cellules souches autologues et allogéniques par l'EBMT
• Actuellement professeur à la faculté de médecine de l'université Yeditepe
• Lauréat du prix du jeune chercheur en aphérèse thérapeutique

Assoc. Prof. Dr. Özlem Köroğlu is a specialist in Physical Medicine and Rehabilitation at Memorial Ankara Hospital (2024–present). She previously served as a faculty member at Gaziler Physical Therapy and Rehabilitation Training and Research Hospital (2016–2024). She was Chief of the Physical Medicine and Rehabilitation Clinic at Elazığ Military Hospital (2011–2015). She earned her MD in 2003 from the GATA Faculty of Medicine. She completed her PM&R residency in 2011.

Her credentials include Ministry of Health–approved certified prolotherapy training. She has taught Prolotherapy and PRP (2022) and Knee Prolotherapy and Campinject (2019). She also taught GETAT and Dextrose Prolotherapy (2018) and ISPRM Ultrasound (2009). She has additional training in musculoskeletal ultrasound, neural therapy, lumbar injections and manipulation, and botulinum toxin treatment for the spastic hand. She attended the Euro‑Mediterranean PRM School in Italy (2010). She is a member of the Turkish Society of PM&R, the Turkish Society for Research and Fight Against Rheumatism, the Association of PM&R Specialists of Türkiye, the Spinal Cord Diseases Association, and the Ankara Medical Chamber.

Dr. Osman Ilhan is a Professor of Internal Diseases. He earned his medical degree at Ankara University in 1978. He completed his specialization in Internal Diseases there in 1982. He became an Associate Professor in 1990 and a Professor in 1996.

He served as a professor at Ankara University from 1997 to 2022. He has worked at Lokman Hekim Akay Hospital since 2023. Earlier, he held roles at MD Anderson Cancer Center (1996–1997), Ankara University (1978–1983; 1988–1995), GATA (1984–1985), and Ulus Hospital (1985–1988).

Plus de 1 100 procédures de lymphome réalisées – Le professeur Weidmann dirige le service d'hématologie de la clinique Nordwest, un centre de premier plan pour les troubles sanguins.

• Spécialisé dans les soins du lymphome hodgkinien et non hodgkinien
• Professeur possédant une vaste expertise académique et clinique
• Plus de 30 ans d'expérience dans les traitements des troubles sanguins
• Dirige l'un des meilleurs départements d'hématologie d'Allemagne

Classé par Forbes parmi les meilleurs médecins d'Israël – le Dr Goldstein dirige le service d'oncologie pédiatrique du centre médical Hadassah.

• Spécialisé en hémato-oncologie pédiatrique depuis plus de 20 ans
• Expert en rétinoblastome et en approches de médecine de précision
• Réalise des greffes de moelle osseuse haplo-identiques pour les enfants
• Membre de quatre associations internationales d'oncologie pédiatrique

Spécialisé dans les cancers hématologiques et les greffes de moelle osseuse avancées – le Dr Alemdar allie l'excellence académique de l'Université Akdeniz à plus de 15 ans de pratique clinique.

• Certifié en oncologie médicale avec une formation complémentaire en médecine interne
• Expert en thérapie par cellules CAR-T et en greffes de cellules souches haplo-identiques
• Membre de l'Association turque d'oncologie médicale
• Travaille au complexe hospitalier Medical Park Antalya, accrédité par la JCI

Le professeur Reuven Or dirige le service d'hématologie et de greffe de moelle osseuse d'Hadassah – un pionnier de l'immunothérapie du cancer et de la thérapie cellulaire.

• Plus de 15 ans de spécialisation dans les greffes de moelle osseuse et les cancers hématologiques
• Directeur médical de la Banque nationale du sang d'Israël et du registre public de moelle osseuse
• Récipiendaire du prestigieux prix Menachem Begin pour ses réalisations médicales
• Formé dans les meilleures institutions en Italie et aux États-Unis
• A publié de nombreux articles de recherche dans des revues médicales

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

 Mali interdisciplinary hospital is integrating conventional, regenerative and precision medicine. It divides into 11 departments, there are 35 beds in total, including 12 intensive care beds, 23 general beds, 2 emergency and operating rooms, 1 plastic surgical room, 1 Gastro-colonoscopic room. Focus on round-trip treatment with modern medical technology to reduce the cost of hospitalization and the healing time. It also integrating regenerative medicine to repair the body and precision medicine for preventing and treating chronic non-communicable diseases (NCDs) with better results, we provide these services in a greenery atmosphere. Allowing clients to receive the following benefits.

1. Far away from NCDs & It’s complication

2. Good quality of life

3. Youthful lively life

4. Longevity

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.